These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 29214591)

  • 1. Congenital Anomalies: Cluster Detection and Investigation.
    Bermejo-Sánchez E; Posada de la Paz M
    Adv Exp Med Biol; 2017; 1031():535-557. PubMed ID: 29214591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clusters of birth defects: emergency and management. A review of some publications.
    Goujard J
    Eur J Epidemiol; 1999 Oct; 15(9):853-62. PubMed ID: 10608366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention, diagnosis and services.
    Bermejo E; Martínez-Frías ML
    Adv Exp Med Biol; 2010; 686():55-75. PubMed ID: 20824439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Birth Defects Cluster Study: a national approach to birth defects cluster investigations.
    Kucik JE; Bitsko RH; Williams L; Lazarus C; Jarman DW; Correa A
    Birth Defects Res A Clin Mol Teratol; 2008 Nov; 82(11):805-11. PubMed ID: 18985695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary prevention of congenital anomalies: recommendable, feasible and achievable.
    Taruscio D; Mantovani A; Carbone P; Barisic I; Bianchi F; Garne E; Nelen V; Neville AJ; Wellesley D; Dolk H
    Public Health Genomics; 2015; 18(3):184-91. PubMed ID: 25791968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reproductive health indicators and fetal medicine - many things will change.
    Olsen J; Pedersen LH
    Scand J Work Environ Health; 2016 Jun; 42(6):561-562. PubMed ID: 27685865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection and investigation of temporal clusters of congenital anomaly in Europe: seven years of experience of the EUROCAT surveillance system.
    Dolk H; Loane M; Teljeur C; Densem J; Greenlees R; McCullough N; Morris J; Nelen V; Bianchi F; Kelly A
    Eur J Epidemiol; 2015 Nov; 30(11):1153-64. PubMed ID: 25840712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Metropolitan Atlanta Congenital Defects Program: 35 years of birth defects surveillance at the Centers for Disease Control and Prevention.
    Correa-Villaseñor A; Cragan J; Kucik J; O'Leary L; Siffel C; Williams L
    Birth Defects Res A Clin Mol Teratol; 2003 Sep; 67(9):617-24. PubMed ID: 14703783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population-based surveillance for rare congenital and inherited disorders: models and challenges.
    Jackson JM; Crider KS; Olney RS
    Adv Exp Med Biol; 2010; 686():133-50. PubMed ID: 20824444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary Prevention of Congenital Anomalies: Special Focus on Environmental Chemicals and other Toxicants, Maternal Health and Health Services and Infectious Diseases.
    Taruscio D; Baldi F; Carbone P; Neville AJ; Rezza G; Rizzo C; Mantovani A
    Adv Exp Med Biol; 2017; 1031():301-322. PubMed ID: 29214580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of sharing and networking among birth defects surveillance programs: an ICBDSR perspective.
    Bermejo-Sánchez E; Botto LD; Feldkamp ML; Groisman B; Mastroiacovo P
    J Community Genet; 2018 Oct; 9(4):411-415. PubMed ID: 30229536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methods for a public health response to birth defects clusters.
    Williams LJ; Honein MA; Rasmussen SA
    Teratology; 2002; 66 Suppl 1():S50-8. PubMed ID: 12239745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital anomalies identified at birth among infants born following assisted reproductive technology in Colorado.
    Moses XJ; Torres T; Rasmussen A; George C
    Birth Defects Res A Clin Mol Teratol; 2014 Feb; 100(2):92-9. PubMed ID: 24532453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening high-risk clusters for developing birth defects in mothers in Shanxi Province, China: application of latent class cluster analysis.
    Cao H; Wei X; Guo X; Song C; Luo Y; Cui Y; Hu X; Zhang Y
    BMC Pregnancy Childbirth; 2015 Dec; 15():343. PubMed ID: 26694165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Birth defects in a cohort of uninfected children born to HIV-infected women].
    Fernández Ibieta M; Ramos Amador JT; Bellón Cano JM; González-Tomé MI; Guillén Martín S; Navarro Gómez M; de José MI; Beceiro J; Iglesias E; Prieto L; Santos MJ; Martínez Guardia N; Roa MA; Regidor J
    An Pediatr (Barc); 2009 Mar; 70(3):253-64. PubMed ID: 19246263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From cause to care: Triple surveillance for better outcomes in birth defects and rare diseases.
    Botto LD; Mastroiacovo P
    Eur J Med Genet; 2018 Sep; 61(9):551-555. PubMed ID: 29902591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using latent class cluster analysis to screen high risk clusters of birth defects between 2009 and 2013 in Northwest China.
    Pei L; Zeng L; Zhao Y; Wang D; Yan H
    Sci Rep; 2017 Jul; 7(1):6873. PubMed ID: 28761054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of seasonal variation of birth defects in Atlanta.
    Siffel C; Alverson CJ; Correa A
    Birth Defects Res A Clin Mol Teratol; 2005 Oct; 73(10):655-62. PubMed ID: 16240376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hospital discharge data: can it serve as the sole source of case ascertainment for population-based birth defects surveillance programs?
    Wang Y; Cross PK; Druschel CM
    J Public Health Manag Pract; 2010; 16(3):245-51. PubMed ID: 20357611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the Western Australian Register of Developmental Anomalies: Thirty-five years of surveillance.
    Nembhard WN; Bower C
    Birth Defects Res A Clin Mol Teratol; 2016 Nov; 106(11):894-904. PubMed ID: 27891787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.